Cost-effectiveness of peripheral catheters with integrated stabilization platform under the perspective of hospitals in Brazil

Abstract

The current evaluation aims at determining the cost-effectiveness of peripheral catheters with securement device, blood control septum and integrated stabilization platform in use in patients admitted to hospitals and submitted to infusion therapy, under the perspective of Supplementary HealthCare in Brazil. A decision tree was elaborated for estimating the incremental cost-effectiveness ratio (ICER) between two types of peripheral catheters, with or without an integrated stabilization platform, in a time horizon of 96 hours. Clinical outcomes applied to the model were obtained from systematic review of literature published up to 31.08.2015 and include rates of venipuncture success and catheter indwell time. The average of total direct medical costs for treatment of adverse events was estimated by expert opinion and data was collected from secondary databases. The Base Case results reflect cost-savings of about 138,31 Brazilian Reais per avoided complications and 558,33 Brazilian Reais per successful venipuncture or new venipunctures avoided. Ours study points out the use of peripheral catheters with stabilization platforms integrated to the device constitutes feasible alternatives for Brazilian private hospitals. Their use can generate reduction of total treatment costs and gains in effectiveness specially due to lower tendencies for development of securement-related adverse reactions, caused by inadvertent mobilization of peripheral access over time.